[LDL-cholesterol levels in a series of HIV-infected patients]

Marisa Gallego1, Rosario Palacios, Julián Olalla

  • 1Hospital Virgen de la Victoria, Málaga, España.

Medicina Clinica
|May 11, 2010
PubMed

Insights

Over 20% of HIV patients did not meet their LDL-cholesterol (LDL-C) goals. Central obesity and longer antiretroviral therapy increased risk, highlighting the need for better lipid management in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Context:

  • HIV-infected patients often have dyslipidemia.
  • Cardiovascular disease is a leading cause of mortality in HIV patients.
  • Current guidelines recommend specific LDL-cholesterol (LDL-C) targets based on cardiovascular risk factors.

Purpose:

  • To determine the prevalence of patients with human immunodeficiency virus (HIV) who do not achieve their target LDL-cholesterol (LDL-C) levels.
  • To identify factors associated with failure to reach LDL-C goals in this population.

Summary:

  • A cross-sectional study of 1019 HIV-infected patients found that 22.8% did not reach their target LDL-C levels.
  • Higher LDL-C levels were associated with obesity (OR=1.98), longer duration of antiretroviral therapy (OR=1.92 per 2 years), and stricter LDL-C targets (OR=16.9 for Groups B/C).
  • Central obesity and time on antiretroviral therapy were significant factors associated with elevated LDL-C.

Impact:

  • Findings indicate a significant unmet need for lipid management in HIV-infected individuals.
  • Identifying risk factors can help tailor interventions to prevent cardiovascular events.
  • This study underscores the importance of monitoring and managing LDL-C in HIV patients to reduce cardiovascular risk.
Abstract